LB Pharmaceuticals

tenant

drug

Sigma-Stim

as of 2026-07-01

Add to landscape Monitor this Compare this Ask about this

at a glance

DEVICE

Pre-approval / investigational in the US

Developed by Michigan State University

1 trials in the graph

Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality

DEVICE

Indications

Investigational (via trials)

Suicidal Ideation Schizo Affective Disorder Depression Suicidal Ideation Bipolar Disorder Depressive Disorder, Major Major Depressive Disorder Bipolar Disorder Psychotic Disorders Suicide

Trials

1

Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy

NCT06529029Phase 2, Phase 3Recruiting

KOLs & investigators

1

Nagy A Youssef, MD, PhDKOL score 5

Facts & assertions

0 sourced

No assertions recorded for this entity.

relationships

The graph out of here

developer

Michigan State University

company

trial

Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy

PHASE2, PHASE3

trial

indication

Suicidal Ideation

indication

Schizo Affective Disorder

indication

indication

Suicidal Ideation

indication

KOL

Nagy A Youssef, MD, PhD

KOL score 5

person